Literature DB >> 7796346

Bone-resorbing activities of 24-epi-1 alpha-hydroxyvitamin D2 and 24-epi-1 alpha,25-dihydroxyvitamin D2.

K Yokoyama1, T Miyahara, M Matsumoto, K Hashimoto, H Komiyama, A Miyanishi, N Kotera, F Maruyama, H Kozuka.   

Abstract

Bone-resorbing activities of 24-epi-1 alpha-hydroxyvitamin D2 [24-epi-1 alpha(OH)D2], 24-epi-1 alpha,25-dihydroxyvitamin D2 [24-epi-1,25(OH)2D2], and 1 alpha,24S,25-trihydroxyvitamin D2 [1,24S,25(OH)3D2], which might be a metabolite of 24-epi-1,25(OH)2D2, were investigated. In an in vitro bone resorption test, the activity of 24-epi-1 alpha(OH)D2 was similar to that of 1 alpha-hydroxyvitamin D3 [1 alpha(OH)D3] at 10(-9) M-10(-6) M. The activity of 24-epi-1,25(OH)2D2 was weaker than that of 1 alpha,25-dihydroxyvitamin D3 [1,25(OH)2D3] at 10(-11) M-10(-8) M. On the other hand, the activity of 1,24S,25(OH)3D2 was similar to that of 24-epi-1,25(OH)2D2 at 10(-11) M-10(-9) M. In the formation assay of osteoclast-like cells, the activity of 24-epi-1 alpha(OH)D2 was weaker than that of 1 alpha(OH)D3 at 10(-7) M. The activity of 24-epi-1,25(OH)2D2 was almost similar to that of 1,25(OH)2D3 at 10(-11) M-10(-7) M. The activity of 1,24S,25(OH)3D2 was significantly weaker than that of 24-epi-1,25(OH)2D2 at 10(-11) M-10(-9) M. In the two experiments, the potencies of 24-epi-1,25(OH)2D2 were about 100 times higher than those of 24-epi-1 alpha(OH)D2. In an in vivo/in vitro bone resorption test, the activity of 24-epi-1 alpha(OH)D2 was almost similar to those of 1 alpha(OH)D3 and 1,25(OH)2D3 and higher than those of 24-epi-1,25(OH)2D2 and 1,24S,25(OH)3D2. 24-epi-1 alpha-(OH)D2 and 1 alpha(OH)D3 were longer lasting than 24-epi-1,25(OH)2D2 and 1,25(OH)2D3 in this experiment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7796346     DOI: 10.1007/bf00298744

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  10 in total

1.  Bone-resorbing activity of analogues of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol: effects of side chain modification and stereoisomerization on responses of fetal rat bones in vitro.

Authors:  P H Stern; T Mavreas
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

2.  Metabolism of 1alpha-hydroxyvitamin D3 to 1alpha, 25-dihydroxyvitamin D3 in perfused rat liver.

Authors:  M Fukushima; Y Suzuki; Y Toira; I Matsunaga; K Ochi; H Nagano
Journal:  Biochem Biophys Res Commun       Date:  1975-09-16       Impact factor: 3.575

3.  Histochemical demonstration of acid phosphatases with naphthol AS-phosphates.

Authors:  M S BURSTONE
Journal:  J Natl Cancer Inst       Date:  1958-09       Impact factor: 13.506

4.  The effects of vitamin D analogues on bone resorption.

Authors:  J J Reynolds; M F Holick; H F DeLuca
Journal:  Calcif Tissue Res       Date:  1974

Review 5.  Structures and biological activities of vitamin D metabolites and their analogs.

Authors:  N Ikekawa
Journal:  Med Res Rev       Date:  1987 Jul-Sep       Impact factor: 12.944

6.  Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures.

Authors:  N Takahashi; H Yamana; S Yoshiki; G D Roodman; G R Mundy; S J Jones; A Boyde; T Suda
Journal:  Endocrinology       Date:  1988-04       Impact factor: 4.736

7.  Unique rearrangement of ergocalciferol side chain in vitro: production of a biologically highly active homologue of 1,25-dihydroxyvitamin D3.

Authors:  Y Tanaka; R R Sicinski; H F DeLuca; H Sai; N Ikekawa
Journal:  Biochemistry       Date:  1986-09-23       Impact factor: 3.162

8.  Comparison of receptor binding, biological activity, and in vivo tracer kinetics for 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and its 24 epimer.

Authors:  T A Reinhardt; C F Ramberg; R L Horst
Journal:  Arch Biochem Biophys       Date:  1989-08-15       Impact factor: 4.013

9.  Biological activity of 1,25-dihydroxyvitamin D2 and 24-epi-1,25-dihydroxyvitamin D2.

Authors:  H F DeLuca; R R Sicinski; Y Tanaka; P H Stern; C M Smith
Journal:  Am J Physiol       Date:  1988-04

10.  Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia.

Authors:  C Shigeno; I Yamamoto; S Dokoh; M Hino; J Aoki; K Yamada; R Morita; M Kameyama; K Torizuka
Journal:  J Clin Endocrinol Metab       Date:  1985-10       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.